News

Featured News

  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | December 4, 2019

    ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases

    Read More

    Press Release | November 8, 2019

    Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting

    Read More

    Press Release | November 6, 2019

    Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting

    Read More

    Press Release | October 28, 2019

    Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting

    Read More

    News | October 23, 2019

    Novartis bets $80M on Pliant’s preclinical NASH prospect

    Read More

    News | July 19, 2019

    Pyxis Oncology Raises $22 Million Series A

    Read More

    News | July 16, 2019

    Genentech inks its latest discovery deal — this time turning to RNA upstart Skyhawk

    Read More

    News | July 8, 2019

    Fattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk’s roster of partners out to drug RNA

    Read More

    News | June 10, 2019

    Aptinyx Reports Top-line Data from Phase 2 in Patients with Fibromyalgia

    Read More

    News | June 3, 2019

    Carisma Therapeutics Names Dr. Robert Petit As Chief Scientific Officer

    Read More

    News | May 27, 2019

    Carisma Therapeutics Featured in Nature Biotechnology’s Top Academic Spin-outs 2018

    Read More

    Press Release | May 14, 2019

    Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer

    Read More

    Press Release | May 6, 2019

    Skyhawk Therapeutics Announces Agreement with Takeda for Neurodegenerative Diseases

    Read More

    News | April 9, 2019

    Pliant Therapeutics Reports Positive Results Of Phase 1 Clinical Study

    Read More

    News | March 1, 2019

    Genome editing company Precision proposes $100M IPO

    Read More

    News | January 16, 2019

    Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

    Read More

    Press Release | January 4, 2019

    Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

    Read More

    News | January 3, 2019

    Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809

    Read More